Skip to content
Homepage
Author:
Cogent Biosciences, Inc.
Posted Date:
August 10, 2026
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
Cogent Biosciences, Inc.
August 10, 2026
Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
Cogent Biosciences, Inc.
June 30, 2026
